179 related articles for article (PubMed ID: 24550155)
1. Smoldering medullary thyroid carcinoma liver metastasis 37 years after resection of an organ-confined tumor.
Waters KM; Ali SZ; Erozan YS; Olson MT
Diagn Cytopathol; 2015 Jan; 43(1):45-8. PubMed ID: 24550155
[TBL] [Abstract][Full Text] [Related]
2. The variable pathologic presentations of medullary and micro-medullary thyroid carcinoma: an institutional experience.
Samulski TD; Livolsi VA; Montone K; Baloch Z
Pathol Res Pract; 2014 Mar; 210(3):182-5. PubMed ID: 24440099
[TBL] [Abstract][Full Text] [Related]
3. Combining serum calcitonin, carcinoembryonic antigen, and neuron-specific enolase to predict lateral lymph node metastasis in medullary thyroid carcinoma.
Ye L; Zhou X; Lu J; Wang Y; Xie X; Zhang J
J Clin Lab Anal; 2020 Jul; 34(7):e23278. PubMed ID: 32141647
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
5. Serum calcitonin negative mixed medullary-follicular carcinoma initially diagnosed as medullary thyroid carcinoma by fine-needle aspiration cytology: A case report and review of the literatures.
Liu Y; Yuan L; Yang D; Jin Y
Diagn Cytopathol; 2018 Aug; 46(8):690-693. PubMed ID: 29524315
[TBL] [Abstract][Full Text] [Related]
6. Medullary thyroid cancer with undetectable serum calcitonin.
Brutsaert EF; Gersten AJ; Tassler AB; Surks MI
J Clin Endocrinol Metab; 2015 Feb; 100(2):337-41. PubMed ID: 25490273
[TBL] [Abstract][Full Text] [Related]
7. Persistent elevation of carcinoembryonic antigen as first presentation of a medullary thyroid carcinoma.
Martins A; Gonçalves A; Almeida T; Midões A
BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29895542
[TBL] [Abstract][Full Text] [Related]
8. Medullary thyroid carcinoma surgical cytoreduction induces an increase in serum calcitonin and carcinoembryonic antigen doubling times.
Papapetrou PD; Polymeris A
Exp Clin Endocrinol Diabetes; 2012 Mar; 120(3):164-8. PubMed ID: 22328112
[TBL] [Abstract][Full Text] [Related]
9. Brain metastasis from calcitonin-negative medullary thyroid carcinoma.
Baptista PF; Fonseca LCM; Carvalho AFC; Silva SNVD; Freitas CRO
Ann Endocrinol (Paris); 2022 Aug; 83(4):258-260. PubMed ID: 35537523
[TBL] [Abstract][Full Text] [Related]
10. Disparity between tissue and serum calcitonin and carcinoembryonic antigen in a patient with medullary thyroid carcinoma.
Alapat DV; Ain KB; Sloan DA; Monaghan KG; Karabakhtsian RG
Endocrine; 2011 Apr; 39(2):148-52. PubMed ID: 21243446
[TBL] [Abstract][Full Text] [Related]
11. Long-term survivor without recurrence after resection of simultaneous solitary pancreatic metastasis from thyroid medullary carcinoma.
Hyodo M; Nagai H; Sata N; Ishitsuka T; Kurihara K; Yoshizawa K; Saitoh K
Hepatogastroenterology; 2003; 50(53):1687-8. PubMed ID: 14571817
[TBL] [Abstract][Full Text] [Related]
12. Hepatic metastases from the spindle cell variant of medullary thyroid carcinoma: report of a case with diagnosis by fine needle aspiration biopsy.
Ibarrola de Andrés C; Castellano Megías VM; Ballestin Carcavilla C; Alberti Masgrau N; Perez Barrios A; De Agustín PA
Acta Cytol; 2001; 45(6):1022-6. PubMed ID: 11726097
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of selected biochemical markers in the detection of recurrence of medullary thyroid cancer - comparison of calcitonin, procalcitonin, chromogranin A, and carcinoembryonic antigen.
Woliński K; Kaznowski J; Klimowicz A; Maciejewski A; Łapińska-Cwojdzińska D; Gurgul E; Car AD; Fichna M; Gut P; Gryczyńska M; Ruchała M
Endokrynol Pol; 2017; 68(4):434-437. PubMed ID: 28585679
[TBL] [Abstract][Full Text] [Related]
14. Small cell medullary thyroid carcinoma: A diagnostic dilemma.
Verma A; Kane S; Vinarkar S; D'Cruz AK
Indian J Pathol Microbiol; 2017; 60(4):562-564. PubMed ID: 29323074
[TBL] [Abstract][Full Text] [Related]
15. Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma.
Bockhorn M; Frilling A; Rewerk S; Liedke M; Dirsch O; Schmid KW; Broelsch CE
Thyroid; 2004 Jun; 14(6):468-70. PubMed ID: 15242577
[TBL] [Abstract][Full Text] [Related]
16. Thyroid metastases from typical carcinoid of the lung differentiating between medullary thyroid carcinoma and neuroendocrine tumor metastasis to the thyroid.
La Rosa S; Imperatori A; Giovanella L; Garancini S; Capella C
Thyroid; 2009 May; 19(5):521-6. PubMed ID: 19415998
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinoma with double negative calcitonin and CEA: a case report and update of literature review.
Gambardella C; Offi C; Clarizia G; Romano RM; Cozzolino I; Montella M; Di Crescenzo RM; Mascolo M; Cangiano A; Di Martino S; Candela G; Docimo G
BMC Endocr Disord; 2019 Oct; 19(1):103. PubMed ID: 31619220
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced ultrasound diagnosis of hepatic metastasis of concurrent medullary-papillary thyroid carcinoma: A case report.
Zhou J; Luo Y; Ma BY; Ling WW; Zhu XL
Medicine (Baltimore); 2017 Dec; 96(50):e9065. PubMed ID: 29390301
[TBL] [Abstract][Full Text] [Related]
19. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of serum calcitonin, CEA and AFP assays in the early detection of medullary thyroid carcinoma relapse].
Łacka K; Michałek K; Majewski P
Wiad Lek; 2002; 55(7-8):394-403. PubMed ID: 12428567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
